Rezultati pretrage - Behl, Deepti

  • Prikaz rezultata 1 – 4 od 4
Detaljiziraj rezultate
  1. 1
    What Do Oncologists Say about Chemotherapy at the Very End of Life? Results from a Semiqualitative Survey

    What Do Oncologists Say about Chemotherapy at the Very End of Life? Results from a Semiqualitative Survey od Behl, Deepti, Jatoi, Aminah

    Izdano 2010
    Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
    Tekst
    Spremi u popis
    Spremljeno u:
  2. 2
    Brain Metastases From Melanoma: Is There a Role for Concurrent Temozolomide in Addition to Whole Brain Radiation Therapy?

    Brain Metastases From Melanoma: Is There a Role for Concurrent Temozolomide in Addition to Whole Brain Radiation Therapy? od Schild, Steven E., Behl, Deepti, Markovic, Svetomir N., Brown, Paul D., Sande, Jonathan R., Deming, Richard L., Rowland, Kendrith M., Bearden, James D.

    Izdano 2010
    Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
    Tekst
    Spremi u popis
    Spremljeno u:
  3. 3
    Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313

    Phase IB/II Randomized Study of FOLFIRINOX Plus Pegylated Recombinant Human Hyaluronidase Versus FOLFIRINOX Alone in Patients With Metastatic Pancreatic Adenocarcinoma: SWOG S1313 od Ramanathan, Ramesh K., McDonough, Shannon L., Philip, Philip A., Hingorani, Sunil R., Lacy, Jill, Kortmansky, Jeremy S., Thumar, Jaykumar, Chiorean, E. Gabriela, Shields, Anthony F., Behl, Deepti, Mehan, Paul T., Gaur, Rakesh, Seery, Tara, Guthrie, Katherine A., Hochster, Howard S.

    Izdano 2019
    Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
    Tekst
    Spremi u popis
    Spremljeno u:
  4. 4
    Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence

    Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence od Slingluff, Craig L, Lewis, Karl D, Andtbacka, Robert, Hyngstrom, John, Milhem, Mohammed, Markovic, Svetomir N, Bowles, Tawnya, Hamid, Omid, Hernandez-Aya, Leonel, Claveau, Joel, Jang, Sekwon, Philips, Prejesh, Holtan, Shernan G, Shaheen, Montaser F, Curti, Brendan, Schmidt, William, Butler, Marcus O, Paramo, Juan, Lutzky, Jose, Padmanabhan, Arvinda, Thomas, Sajeve, Milton, Daniel, Pecora, Andrew, Sato, Takami, Hsueh, Eddy, Badarinath, Suprith, Keech, John, Kalmadi, Sujith, Kumar, Pallavi, Weber, Robert, Levine, Edward, Berger, Adam, Bar, Anna, Beck, J Thaddeus, Travers, Jeffrey B, Mihalcioiu, Catalin, Gastman, Brian, Beitsch, Peter, Rapisuwon, Suthee, Glaspy, John, McCarron, Edward C, Gupta, Vinay, Behl, Deepti, Blumenstein, Brent, Peterkin, Joanna J

    Izdano 2021
    Preuzmi cijeli tekst Preuzmi cijeli tekst Preuzmi cijeli tekst
    Tekst
    Spremi u popis
    Spremljeno u:

Alati za pretragu: